Finance

Lists
MED:NYSE
Medifast Inc
$11.51
-1.37%
(-0.16) 1D
$11.51
0.00% (0.00)
After hours
Closed: Oct 6, 4:00:06 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MED...
Open
$11.71
High
$11.86
Low
$11.51
Mkt. cap
129.35M
Avg. vol.
116.31K
Volume
0.00
52-wk high
$14.15
52-wk low
$9.22
EPS
-$2.33
Beta
0.68
Shares outstanding
11.18M
No. of employees
380
Open
$11.71
High
$11.86
Low
$11.51
Mkt. cap
129.35M
Avg. vol.
116.31K
Volume
0.00
52-wk high
$14.15
52-wk low
$9.22
EPS
-$2.33
Beta
0.68
Shares outstanding
11.18M
No. of employees
380
News stories
From web sources and news partners
Profile
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics. Wikipedia
About Medifast Inc
CEODaniel R. Chard | Daniel R. Chard
Employees380
Founded1981
Headquarters-
SectorPersonal care products
Websitemedifastinc.com
Analyst ratings
Based on 1 analyst giving stock ratings to MED in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for MED in the last 3 months
Highest
Current $11.51
$12.00 (+4.26%)
Average
$12.00 (+4.26%)
Lowest
$12.00 (+4.26%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jim Salera
Stephens
Hold
Maintained
$12.00
+4.3%
08/04/2026
Last report
Aug 3, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.28 / -$0.65
+56.92%beat
Revenue / Est. (USD)
76.38M / 72.70M
+5.07%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
89.41M
75.10M
76.04M
76.38M
Cost of goods sold
27.25M
22.96M
24.29M
22.99M
Cost of revenue
27.25M
22.96M
24.29M
22.99M
Research and development expenses
1.10M
1.00M
1.10M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
65.14M
58.94M
56.14M
57.72M
Operating expense
66.24M
59.94M
57.24M
57.72M
Total operating expenses
93.49M
82.90M
81.52M
80.71M
Operating income
-4.08M
-7.80M
-5.48M
-4.33M
Other non operating income
-2.00K
1.00K
16.00K
-11.00K
EBT including unusual items
-2.66M
-6.38M
-1.94M
-2.99M
EBT excluding unusual items
-2.66M
-6.38M
-4.08M
-2.99M
Income tax expense
-396.00K
11.74M
181.00K
109.00K
Effective tax rate
14.90%
-183.91%
-9.32%
-3.64%
Other operating expenses
-
-
-
-
Net income
-2.26M
-18.12M
-2.12M
-3.10M
Net profit margin
-2.53%
-24.13%
-2.79%
-4.06%
Earnings per share
-0.21
-1.65
-0.19
-0.28
Interest and investment income
1.43M
1.42M
1.38M
1.35M
Interest expense
-
-
-
-
Net interest expenses
1.43M
1.42M
1.38M
1.35M
Depreciation and amortization charges
-
-
-
-
EBITDA
-629.00K
-4.34M
-2.00M
-881.00K
Gain or loss from assets sale
606.00K
372.00K
-2.12M
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps